NVCT
Nuvectis Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$24.49
+0.49%2
Insider buys (3m)
0
Insider sells (3m)
$1.2M
Net value (3m)
+161.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 5, 2026 | Carson Michael J. · officer: Vice President, Finance | A-Award | 30,000 | $0.00 |
| Jul 1, 2026 | Mosseri Marlio Charles · 10 percent owner | Purchase | 50,000 | $18 |
| Jul 1, 2026 | BENTSUR RON · director, 10 percent owner, officer: Chairman & CEO | Purchase | 12,500 | $20 |
| Jun 12, 2026 | Hoberman Kenneth · director | A-Award | 35,000 | $0.00 |
| Jun 12, 2026 | Oliviero James F III · director | A-Award | 35,000 | $0.00 |
| Jun 12, 2026 | Sanchez Juan · director | A-Award | 35,000 | $0.00 |
| Jun 12, 2026 | Kaplan Matthew L. · director | A-Award | 35,000 | $0.00 |
| Jan 9, 2026 | Carson Michael J. · officer: Vice President, Finance | A-Award | 61,200 | $0.00 |
| Jan 9, 2026 | Poradosu Enrique · officer: Chief Science & Business Off | A-Award | 150,000 | $0.00 |
| Jan 9, 2026 | Shemesh Shay · officer: Chief Dev. & Ops. Officer | A-Award | 150,000 | $0.00 |
| Jan 9, 2026 | BENTSUR RON · director, 10 percent owner, officer: Chairman & CEO | A-Award | 150,000 | $0.00 |
| Nov 6, 2025 | Kaplan Matthew L. · director | Purchase | 11,000 | $5.84 |
| Nov 6, 2025 | BENTSUR RON · director, 10 percent owner, officer: Chairman & CEO | Purchase | 5,000 | $5.72 |
| Nov 6, 2025 | Sanchez Juan · director | Purchase | 13,000 | $5.79 |
| Oct 31, 2025 | Sanchez Juan · director | A-Award | 30,000 | $0.00 |
| Oct 29, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 72,836 | $6.28 |
| Oct 29, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 35,034 | $6.15 |
| Oct 29, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 46,900 | $6.06 |
| Jun 24, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 5,603 | $7.99 |
| Jun 20, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 28,043 | $8.05 |
| Jun 20, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 5,399 | $8.11 |
| Jun 12, 2025 | Kaplan Matthew L. · director | A-Award | 30,000 | $0.00 |
| Jun 12, 2025 | Oliviero James F III · director | A-Award | 30,000 | $0.00 |
| Jun 12, 2025 | Hoberman Kenneth · director | A-Award | 30,000 | $0.00 |
| May 13, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 21,167 | $8.11 |
| May 12, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 5,395 | $8.98 |
| May 12, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 9,817 | $8.90 |
| May 12, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 9,850 | $8.95 |
| May 12, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 2,400 | $8.97 |
| May 12, 2025 | Mosseri Marlio Charles · 10 percent owner | Purchase | 100 | $8.71 |
Institutional positioning
13F filings over the trailing two quarters
New 16Increased 21Reduced 12Sold out 60
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 764,441 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 659,879 | May 15, 2026 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | Increased | 651,757 | Apr 24, 2026 |
| Occam Crest Management LP | Increased | 407,147 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 384,105 | May 15, 2026 |
| BALDWIN BROTHERS LLC/MA | Reduced | 378,625 | Apr 14, 2026 |
| CITADEL ADVISORS LLC | Increased | 182,232 | Sep 2, 2026 |
| STATE STREET CORP | Increased | 166,516 | May 15, 2026 |
| NORTHERN TRUST CORP | Increased | 124,212 | May 14, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 114,842 | May 8, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 105,286 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 92,154 | May 8, 2026 |
| CITADEL ADVISORS LLC | Reduced | 78,425 | May 15, 2026 |
| OPPENHEIMER & CO INC | Unchanged | 73,566 | Apr 24, 2026 |
| FORBES J M & CO LLP | Unchanged | 59,000 | Apr 16, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 5, 2026